InSilicoTrials

MILAN, June 27, 2023 /PRNewswire/ — COSBI, a leading research center specializing in systems biology, and InSilicoTrials, a leading provider of artificial intelligence (AI) and simulation tools for drug and medical device development, have forged a groundbreaking strategic agreement aimed at revolutionizing drug development by leveraging the unique strengths of both entities. InSilicoTrials COSBI collaboration … Read more

MILAN, May 25, 2023 /PRNewswire/ — InSilicoTrials – a leading provider of artificial intelligence and simulation tools for drug and medical device development, and IBSA Group – one of the major players worldwide in the fields of Reproductive Medicine and hyaluronic acid-based products, have partnered to revolutionize drug development processes using in silico medicine. Graphic … Read more